The event of pancreatic most cancers is dependent on numerous oncogenic modifications. Kras would be the most often mutated gene (G12D allele) in pancreatic cancer and it is present in 95% of pancreatic cancers26. Despite the fact that genetically engineered mouse (GEM) designs have convincingly demonstrated that constitutive activation of Kras by